
Gregory J. Tryder
Supervisory Patent Examiner (ID: 19032, Phone: (571)270-7365 , Office: P/2617 )
| Most Active Art Unit | 2629 |
| Art Unit(s) | 2600, 2617, 2692, 2626, 2629 |
| Total Applications | 245 |
| Issued Applications | 113 |
| Pending Applications | 0 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6468983
[patent_doc_number] => 20100190996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-29
[patent_title] => 'Process for the Preparation of Losartan'
[patent_app_type] => utility
[patent_app_number] => 11/990456
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3687
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20100190996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11990456
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/990456 | Alternative process for the preparation of losartan | Dec 20, 2005 | Issued |
Array
(
[id] => 5446012
[patent_doc_number] => 20090047238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Novel Spirotropane Compounds And Methods For The Modulation Of Chemokine Receptor Activity'
[patent_app_type] => utility
[patent_app_number] => 11/792577
[patent_app_country] => US
[patent_app_date] => 2005-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29730
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047238.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792577
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792577 | Spirotropane compounds and methods for the modulation of chemokine receptor activity | Dec 8, 2005 | Issued |
Array
(
[id] => 408254
[patent_doc_number] => 07285572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-10-23
[patent_title] => 'CaSR antagonist'
[patent_app_type] => utility
[patent_app_number] => 11/286378
[patent_app_country] => US
[patent_app_date] => 2005-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22034
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/285/07285572.pdf
[firstpage_image] =>[orig_patent_app_number] => 11286378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/286378 | CaSR antagonist | Nov 24, 2005 | Issued |
Array
(
[id] => 510877
[patent_doc_number] => 07196109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-27
[patent_title] => 'Aminoindazole derivatives as medicaments and pharmaceutical compositions including them'
[patent_app_type] => utility
[patent_app_number] => 11/285874
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11746
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/196/07196109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285874
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285874 | Aminoindazole derivatives as medicaments and pharmaceutical compositions including them | Nov 22, 2005 | Issued |
Array
(
[id] => 5875499
[patent_doc_number] => 20060167070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Triazole compounds that modulate Hsp90 activity'
[patent_app_type] => utility
[patent_app_number] => 11/282119
[patent_app_country] => US
[patent_app_date] => 2005-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 49997
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11282119
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/282119 | Triazole compounds that modulate Hsp90 activity | Nov 16, 2005 | Issued |
Array
(
[id] => 833562
[patent_doc_number] => 07396852
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-08
[patent_title] => 'Compound having indolocarbazole moiety and divalent linkage'
[patent_app_type] => utility
[patent_app_number] => 11/280552
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5549
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396852.pdf
[firstpage_image] =>[orig_patent_app_number] => 11280552
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/280552 | Compound having indolocarbazole moiety and divalent linkage | Nov 15, 2005 | Issued |
Array
(
[id] => 4933546
[patent_doc_number] => 20080004321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Potentiators of Glutamate Receptors'
[patent_app_type] => utility
[patent_app_number] => 11/718742
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23193
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20080004321.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718742
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718742 | Potentiators of glutamate receptors | Nov 14, 2005 | Issued |
Array
(
[id] => 5614479
[patent_doc_number] => 20060116407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Amide derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/274497
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18434
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116407.pdf
[firstpage_image] =>[orig_patent_app_number] => 11274497
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/274497 | Amide derivatives | Nov 14, 2005 | Abandoned |
Array
(
[id] => 5777401
[patent_doc_number] => 20060106041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Synthesis of indole analogs of 1-benzyl-3-(5\'-hydroxymethy 1-2\' -furyl) indazole (YC-1) as anti-platelet agents'
[patent_app_type] => utility
[patent_app_number] => 11/274436
[patent_app_country] => US
[patent_app_date] => 2005-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6333
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20060106041.pdf
[firstpage_image] =>[orig_patent_app_number] => 11274436
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/274436 | Synthesis of indole analogs of 1-benzyl-3-(5′-hydroxymethyl-2′-furyl) indazole (YC-1) as anti-platelet agents | Nov 14, 2005 | Issued |
Array
(
[id] => 300028
[patent_doc_number] => 07538230
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-26
[patent_title] => 'Letrozole production process'
[patent_app_type] => utility
[patent_app_number] => 11/273276
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5982
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/538/07538230.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273276
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273276 | Letrozole production process | Nov 13, 2005 | Issued |
Array
(
[id] => 5866073
[patent_doc_number] => 20060100204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Anti-cytokine heterocyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/270207
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19393
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100204.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270207
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270207 | Anti-cytokine heterocyclic compounds | Nov 8, 2005 | Issued |
Array
(
[id] => 330574
[patent_doc_number] => 07511070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-31
[patent_title] => 'Compounds and therapies for the prevention of vascular and non-vascular pathologies'
[patent_app_type] => utility
[patent_app_number] => 11/270185
[patent_app_country] => US
[patent_app_date] => 2005-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 22
[patent_no_of_words] => 32774
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/511/07511070.pdf
[firstpage_image] =>[orig_patent_app_number] => 11270185
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/270185 | Compounds and therapies for the prevention of vascular and non-vascular pathologies | Nov 8, 2005 | Issued |
Array
(
[id] => 4460197
[patent_doc_number] => 07894695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Tricyclic spacer systems for nonlinear optical devices'
[patent_app_type] => utility
[patent_app_number] => 11/666399
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 5139
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/894/07894695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11666399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/666399 | Tricyclic spacer systems for nonlinear optical devices | Oct 25, 2005 | Issued |
Array
(
[id] => 5564795
[patent_doc_number] => 20090137648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'PROCESS FOR THE PREPARATION OF IRBESARTAN HYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 11/718059
[patent_app_country] => US
[patent_app_date] => 2005-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9510
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137648.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718059
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718059 | Process for the preparation of irbesartan hydrochloride | Oct 25, 2005 | Issued |
Array
(
[id] => 535853
[patent_doc_number] => 07176223
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => 'Method for synthesis of 5-(3-pyridylmethylene-)imidazolidine-2,4-dione'
[patent_app_type] => utility
[patent_app_number] => 11/256910
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2250
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176223.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256910
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256910 | Method for synthesis of 5-(3-pyridylmethylene-)imidazolidine-2,4-dione | Oct 23, 2005 | Issued |
Array
(
[id] => 4826865
[patent_doc_number] => 20080125409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => '1,5-Diheterocycle-1H-Triazole Derivative'
[patent_app_type] => utility
[patent_app_number] => 11/577476
[patent_app_country] => US
[patent_app_date] => 2005-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38156
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577476
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577476 | 1,5-Diheterocycle-1H-Triazole Derivative | Oct 18, 2005 | Abandoned |
Array
(
[id] => 443122
[patent_doc_number] => 07256210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => '7-amido-isoindolyl compounds and methods of their use'
[patent_app_type] => utility
[patent_app_number] => 11/250408
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34138
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/256/07256210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11250408
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/250408 | 7-amido-isoindolyl compounds and methods of their use | Oct 16, 2005 | Issued |
Array
(
[id] => 5821099
[patent_doc_number] => 20060025412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Peptide deformylase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/178823
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8605
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025412.pdf
[firstpage_image] =>[orig_patent_app_number] => 11178823
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/178823 | Peptide deformylase inhibitors | Oct 13, 2005 | Abandoned |
Array
(
[id] => 5194575
[patent_doc_number] => 20070083059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Method for preparing a dialkyl carbonate, and its use in the preparation of diaryl carbonates and polycarbonates'
[patent_app_type] => utility
[patent_app_number] => 11/248390
[patent_app_country] => US
[patent_app_date] => 2005-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3725
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20070083059.pdf
[firstpage_image] =>[orig_patent_app_number] => 11248390
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/248390 | Method for preparing a dialkyl carbonate, and its use in the preparation of diaryl carbonates and polycarbonates | Oct 11, 2005 | Issued |
Array
(
[id] => 876403
[patent_doc_number] => 07358238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-15
[patent_title] => 'Pharmaceutical use of fused 1,2,4-triazoles'
[patent_app_type] => utility
[patent_app_number] => 11/247847
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15881
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/358/07358238.pdf
[firstpage_image] =>[orig_patent_app_number] => 11247847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/247847 | Pharmaceutical use of fused 1,2,4-triazoles | Oct 10, 2005 | Issued |